Phase I Studies: On Time with Quality Data

July 24, 2024

Consistent Early Phase Milestone Achievement

Backed by select partnerships with Phase I Specialty Units and a tenured team, CRC consistently reaches milestones under tight clinical timelines in early phase studies. Learn how our strategic approach and robust collaboration led to dosing the last subject two weeks ahead of schedule while maintaining data quality in the case study below.

< Older Post

Newer Post >
Principal investigator and clinical research associate

4 Ways Strategic Site Selection Maximizes the Value Equation

April 10, 2025
In clinical trials, success hinges not just on protocol design and quality data but on choosing the right investigative sites and engaging them effectively. Here are four key reasons why strategic site selection is critical for maximizing value in your clinical trials.

Expedited Completion of a Complex Driving Study

March 26, 2025
Driving In the Fast Lane
A damaged car is sitting on the side of the road in the rain.

Next-Day Effects: Are Medications Leaving Drivers at Risk?

December 18, 2024
Since 2018, more than 30 drugs with the potential to impair driving ability have been approved without a dedicated driving study, despite clearly meeting the FDA criteria for such studies based on a conservative application of these criteria.
Show More